Biocodex is committed to improving the health and well-being of patients and consumers around the world at every stage of their lives, focusing on three areas of expertise: microbiota care, women’s health and orphan diseases. Our broad product range includes medication (prescription, over-the-counter and orphan drugs), food supplements, medical devices and dermocosmetics. In addition to product development, we invest significant resources in ongoing research, education and innovation to provide the best possible care.
As a pioneer in feminine hygiene products and a market leader in France and Belgium, we aim to continue supporting women throughout the world daily and at every stage of their lives. We innovate constantly to bring effective solutions for women's health, comfort and well-being. Our commitment to women includes effective quality products, expert advice and a responsible attitude to the environment and society at large.
Biocodex develops and markets drugs for patients with severe orphan diseases. In the early 1990’s, we developed an anti-epileptic drug indicated for a newly discovered rare and severe epileptic disorder. Since then, we have been committed to raising awareness of rare epilepsies alongside healthcare professionals, patients and caregivers.